
Explore AstraZeneca PLC's June 2025 report detailing an insider transaction by CFO Aradhana Sarin, showcasing corporate governance through a charitable gift of shares.
Explore AstraZeneca PLC's June 2025 report detailing an insider transaction by CFO Aradhana Sarin, showcasing corporate governance through a charitable gift of shares.
Explore critical insights from Costco's June 10, 2025 8-K report, detailing corporate changes and stock information. Stay informed on significant developments.
Discover significant corporate developments at Cognizant Technology Solutions in this 8-K filing dated June 3, 2025. Stay informed on market impacts and compliance with SEC standards.
Discover Broadcom Inc.'s latest 8-K filing detailing significant corporate events on June 5, 2025. Stay informed on AVGO stock updates and company insights.
Explore Intuit Inc.'s latest 8-K filing revealing significant developments, stock info, and corporate details crucial for investors. Stay informed on INTU's status.
Explore key insights from Coca-Cola Europacific Partners' May 2025 6-K filing. Strong governance, shareholder support, and recommendations for investors.
Explore CCEP's latest 6-K report detailing board committee changes, new appointments, and governance updates. Learn about its global operations and market presence.
Explore Vertex Pharmaceuticals Inc.'s recent 8-K filing, revealing significant corporate changes and insights for investors. Stay informed about VRTX's latest developments.
Explore Marriott's latest 8-K/A filing detailing Sean Tresvant's election to the Board and his committee appointments, emphasizing tech oversight and social impact.
Discover Automatic Data Processing Inc's (ADP) latest 8-K filing details, including SEC info, stock updates, and corporate identity. Stay informed on major shareholder events.
Explore Exelon Corporation's latest 8-K filing from May 2, 2025, detailing significant corporate events and insights vital for investors and stakeholders.
Explore insights from Coca-Cola Europacific Partners' SEC filing, detailing executive share acquisitions and market conditions. Investment recommendation: Hold for cautious optimism.